Press releases

14 Jan 2014

Synthon Biopharmaceuticals ramping up for initiation of Phase I study with its frontrunner ADC SYD985

read more
12 Mar 2013

Leica Biosystems and Synthon Biopharmaceuticals partner to develop a companion diagnostic program for targeted cancer therapies

read more
22 Jan 2013

Synthon Biopharmaceuticals reports positive early results with its second generation HER2-antibody-drug conjugate

read more
18 Jul 2012

Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab

read more
20 Apr 2012

Synthon acquires LEX System from Biolex Therapeutics

read more
22 Mar 2012

Synthon successfully concluded Phase I clinical trial for trastuzumab

read more
23 Jun 2011

Synthon acquires Syntarga and its antibody-drug conjugate technology

read more